Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coal tar effects on skin barrier markers in adults with atopic dermatitis
NL-OMON40845Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2014
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of coal tar in atopic dermatitis (AD), sponsored by Amsterdam University Medical Center. Primary endpoints: Change in natural moisturizing factor levels, Change in lipid levels and 3 more. Started Sep 2014; status: active, not recruiting.
02
Drugs
coal tar
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NL-OMON40845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40845.